Pharmaceutical Technology
NOVEMBER 15, 2022
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This also has clear advantages in healthcare settings, particularly when it comes to vaccines. In general, a prefilled syringe is clearly preferred for vaccines.”. A new challenge .
pharmaphorum
MAY 17, 2022
Expect exclusive data from the movers and shakers in mRNA vaccine and therapy development, 75+ world-class speakers, 5 dedicated tracks of content, and 45+ deep-dive case studies. Rituparna Das, VP – COVID Vaccines, Moderna. Pervin Anklesaria, Deputy Director, HIV Vaccines & Biologics, Bill & Melinda Gates Foundation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
NOVEMBER 1, 2022
If you want to learn more about the Rankings and the range of marketing materials and options available to promote your achievement then please get in touch with us or download the Media Pack : Contact: Sundeep Makkar – Sundeep.Makkar@Verdict.co.uk. This category highlights companies that have launched new medical devices.
Roots Analysis
FEBRUARY 26, 2024
Given the robust pipeline of biologics, which include monoclonal antibodies, vaccines and other protein-based therapeutic products, subcutaneous medications are being investigated for various clinical candidates across different phases of development. You can also download the SAMPLE REPORT on subcutaneous medications by Roots Analysis.
Pharmaceutical Technology
SEPTEMBER 15, 2022
The increase in the production of biological drugs such as vaccines, gene and cell therapies, and monoclonal antibodies, is increasing the volume of injectable drug products in the global healthcare market.
Pharmaceutical Technology
NOVEMBER 4, 2022
For the pharmaceutical industry, disorder in the supply chain can be catastrophic especially when it comes to life saving and sustaining drugs. Global shortages of critical drugs are a growing issue, as demonstrated by the recent challenges around cold chains for COVID vaccines. The CMO solution.
Pharmaceutical Technology
FEBRUARY 1, 2023
RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.
Expert insights. Personalized for you.
52 
Let's personalize your content